RECRUITING

H5N1 Milk Detection Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine whether drinking pasteurized milk (milk heated to kill harmful germs) that contains inactive particles of a flu virus called A(H5) could lead to the detection of the virus in the nose or throat. Inactive particles are not capable of causing disease. The results will help the Centers for Disease Control and Prevention (CDC) better understand how milk consumption could affect flu surveillance. Investigators also want to see if the body produces antibodies in response to this milk consumption.

Official Title

Investigation of Impact of Milk Consumption on H5 Influenza Detection in Respiratory Specimens

Quick Facts

Study Start:2025-05-09
Study Completion:2025-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06850298

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 64 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Individuals aged 18-64 years
  2. * BMI ≤ 35 kg/m2
  3. * Able to understand and give informed consent (American English) and comply with study visits and procedures.
  4. * In good general health based on medical history and the investigator's clinical judgment.
  1. * Symptoms of acute respiratory illness or conjunctivitis within 7 days
  2. * Febrile illness in the previous 72 hours
  3. * Recent influenza antiviral use (within 14 days)
  4. * Immunosuppression due to illness or medications
  5. * Current pregnancy or breastfeeding
  6. * History of allergy or intolerance to milk or milk alternatives
  7. * Consumption of raw (unpasteurized) milk within the previous 14 days
  8. * Recent work (within 14 days) on a farm with animals known to be infected with A(H5) virus
  9. * Previous receipt of A(H5) vaccine at any time

Contacts and Locations

Study Contact

Daniel Graciaa, MD, MPH, MSc
CONTACT
404-712-1370
dsgraci@emory.edu

Principal Investigator

Daniel Graciaa, MD, MPH, MSc
PRINCIPAL_INVESTIGATOR
Emory University

Study Locations (Sites)

Hope Clinic
Atlanta, Georgia, 30322
United States

Collaborators and Investigators

Sponsor: Emory University

  • Daniel Graciaa, MD, MPH, MSc, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-09
Study Completion Date2025-09

Study Record Updates

Study Start Date2025-05-09
Study Completion Date2025-09

Terms related to this study

Keywords Provided by Researchers

  • Pasteurized Milk
  • Flu Virus A (H5)
  • H5N1 avian influenza A

Additional Relevant MeSH Terms

  • Influenza